Dr Martin Turner who's head of policy and public affairs at the BioIndustry Association tells Proactive London it's a golden age of biotech currently with many more people wanting to get involved and invest in the sector. He says for newcomers to the space it's important they familiarise themselves with the clinical trial process as well as the different types of therapies and the science behind them. He says that as traditional sectors continue to suffer with the market disruption brought about by coronavirus, biopharma and healthcare is one of the few economic sectors to have largely escaped the global downturn.
04 Sep 20